Top compounds associated with response to EIF2S3


Feature Type Standardized
Nominal ANOVA
mRNA Gemcitabine gCSI pan-cancer AAC 0.14 0.01
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.01
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.084 0.01
mRNA NG-25 GDSC1000 pan-cancer AAC 0.075 0.01
mRNA MLN4924 CTRPv2 pan-cancer AAC 0.086 0.01
mRNA SB 216763 GDSC1000 pan-cancer AAC 0.096 0.01
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC 0.08 0.01
mRNA leptomycin B CTRPv2 pan-cancer AAC 0.085 0.01
mRNA BAY 61-3606 GDSC1000 pan-cancer AAC 0.086 0.01
mRNA brivanib CTRPv2 pan-cancer AAC 0.09 0.02
Download CSV